Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term Erdosteine for chronic cough in chronic bronchitis phenotype COPD
2011-000620-14Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of erdosteine in chronic obstructive pulmonary disease (COPD), chronic bronchitis (CB) and chronic cough, sponsored by Azienda Ospedaliero-Universitaria Careggi. Primary endpoints: VAS score of cough sensitivity, Cough score from the Leicester Cough Questionnaire and 1 more. Started Dec 2011; status: active.
02
Drugs
erdosteine
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)chronic cough
Beyond the preview
Go deeper on 2011-000620-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000620-14.